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The role of adrenergic receptors in cortisol-induced hyperglycaemia is not well known. The present 
study investigates the effects of adrenergic receptor blockers in cortisol-induced hyperglycaemia in the 
common African toad (Bufo regularis). Each toad was fasted and anesthetized with sodium 
pentobarbitone (3 mg/100 g i.p). The animals (control) received intravenous (i.v) injection of 0.7% 
amphibian saline while animals (untreated) were given cortisol (20 µg/kg). In pre-treatment groups, 
animals received prazosin (0.2 mg/kg i.v), propranolol 0.5 mg/kg or combination of prazosin (0.2 mg/kg 
i.v) and propranolol (0.5 mg/kg i.v) before i.v injection of cortisol (20 µg/kg). Thereafter, blood samples 
were collected for estimation of blood glucose level using the modified glucose oxidase method. 
Cortisol caused significant increase in blood glucose level from 44.4±3.8 to 71.7±9.7 mg/dl. Pre-
treatment of the toads with propranolol (0.5 mg/kg i.v) caused significant reduction (p≤ 0.01) in cortisol-
induced hyperglycaemia while pre-treatment with prazosin (0.2 mg/kg i.v) produced no significant effect 
on hyperglycaemia induced by cortisol. The combination of both prazosin and propranolol completely 
abolished the effects of cortisol on blood glucose level. The results suggest that cortisol-induced 
hyperglycaemia in the toad (B. regularis) is mediated probably by both the α- and β-adrenergic 
receptors with the beta adrenergic receptors playing dominant role. 
 





Cortisol is a well known hyperglycaemic agent. The 
hyperglycaemic effect has been reported in frogs (Hanke, 
1974, 1978; Broughton and Deroos, 1984) and other 
animal species (Chan and Woo, 1978a; Leach and 
Taylor, 1982; Pretty et al., 2009). Its hyperglycaemic 
action is due to activation of gluconeogenesis (Baxter, 
1979; Renaud and Moon, 1980; Khani and Tayek, 2001). 
The hyperglycaemic response to cortisol involves 
metabolic actions such as glucose release from the liver 
as a product of glycogenolysis, increase in gluconeo-
genesis and decrease in peripheral glucose utilisation. 
The relative contribution of each of these effects differ in 
different species and under different nutritional conditions 
(Hanke,1978).The hyperglycaemia develops slowly, 
suggesting that protein catabolism and enzyme activation 
are necessary before glucose release. Corticosteroids 
interact with the sympathoadrenal system to enhance the 
actions of catecholamines and affect glucose metabolism 
and insulin sensitivity through a signaling pathway 
involving or intersecting with catecholamines and the 
sympathetic nervous system (Pretty et al., 2009). 
Previous studies in rats show that adrenal glucocorticoids 
facilitated beta receptors function in vivo and that 
adrenalectomy resulted in loss of responsiveness to
  





to catecholamines (Davies et al., 1981; Davies and 
Lefkowtiz, 1984; Taylor and Hancox, 2000).The study of 
Yang and Zhang (2004) shows that corticosteroid 
hormones have permissive effect to the catecholamine 
through glucocorticoid receptors. Adrenergic receptors 
transmit adrenaline and noradrenaline signals between 
cells (Gilsbach and Hein, 2008) and are important 
mediators of physiologic responses to endogenous cate-
cholamines (Gilsbach and Hein, 2012). Previous studies 
show also that there is interaction between the hormones 
adrenaline and cortisol in their physiologic actions (Peter, 
2011; George et al., 2013). However, while the receptors 
mediating the hyperglycaemic response to other 
hormones like adrenaline and other sympathomimetics 
amines have been studied, the role of adrenergic 
receptors in cortisol-induced hyperglycaemia in amphi-
bians has not received much attention. The aim of the 
present study was to find out the possible role of alpha 
and beta adrenergic receptors in cortisol-induced 




MATERIALS AND METHODS 
 
Experiments were carried out on 240 adult toads (B. regularis) of 
both sexes weighing between 70-100 g. The toads were obtained 
from the banks of slow-moving streams, around ponds and wet 
bushes. The collection process is that of randomly picking the toads 
as one finds them during the night search. Hence selection of the 
animal is unbiased. Each animal was fasted 24 h before the start of 
the experiment and anaesthesized with sodium pentobarbitone 3 
mg/100 g body weight given intraperitoneally. The animal was 
secured on its back on a dissecting board. The truncus arteriosus 
was dissected free from surrounding connective tissue and used for 
blood collection. The anterior abdominal vein was cannulated for 
drug injection. Each toad was heparinised (170 units/0.1 ml) and 
allowed 30 min stabilization. After stabilization period, basal blood 
collection (0 min) was made from the truncus arteriosus. 
The animals were randomly divided into five groups (1-V) of 48 
toads per group. Toads in group I (control) received intravenous 
(i.v) injection of 0.7 % amphibian saline while toads in group II 
(untreated) received cortisol (20 µg/kg i.v). Toads in groups III, IV, 
and V were pre-treated with prazosin (0.2 mg/kg i.v), propranolol 
(0.5 mg/kg i.v), or combination prazosin (0. mg/kg i.v) and 
propranolol (0.5 mg/kg i.v), respectively, 30 min before injection of 
cortisol (20 µg/kg i.v). In each animal, 0.05 ml per sample was 
drawn directly from the truncus arteriousus for glucose 
determination. Blood samples were collected at time interval of 0, 5, 
10, 20, 30, 60, and 90 min, post-injection. Each drug injection was 
in a total volume between 0.1 and 0.12 ml given intravenously 
through the anterior abdominal vein cannula. Blood glucose was 
determined immediately using modified glucose oxidase method of 
Trinder (1969). Because of the small size of the toad, animals were 
sampled only once in each experiment and then sacrificed. 
 
 
Determination of liver and muscle glycogen 
 
To determine the glycogen content of B. regularis, six toads were 
collected and used per group. After surgical procedure and 30 min 
stabilization period, each animal was given 0.7% amphibian saline 
(control group) through anterior abdominal vein cannula. For the 
cortisol group, each animal received 20 μg/kg cortisol injection. In  




pre-treatment groups, animals received either prazosin (0.2 mg/kg 
i.v), (propranolol 0.5 mg/kg i.v) or combination of prazosin (0.2 
mg/kg i.v) and propranolol (0.5 mg/kg i.v) before i.v injection of 
cortisol (20μg/kg). Thereafter, the whole liver and gastrocnemius 
muscle of each animal were removed quickly, 60 min post injection 
under anaesthesia, cleared of adherent tissues and blood was 
blotted away using blotting paper. They were weighed separately 
using an electronic weighing balance, model DT 1000 England. 
Immediately, one gram each of the liver and muscle of the toad was 
removed separately and the glycogen content determined using 
anthrone reagents method (Seifter et al., 1950; Jermyn, 1975). 
 
 
Isolation and purification of glycogen 
 
1 g of the liver and 1 g of the muscle each were placed in individual 
pre-heated Erlnmeyer flasks containing 10 ml of 30% KOH solution. 
The liver and muscle were digested separately by heating the flasks 
for 20 min in a steam bath with occasional shaking until the tissues 
dissolved. The solution was allowed to cool. Then, 4 ml of the 
aliquot from each of the flasks was taken and placed in a 15 ml 
centrifuge tube each. 5 ml of 95% ethanol was added to each 
sample, mixed and centrifuged for 5 min; it was then decanted and 
drained for 5 min. The glycogen precipitated from each sample was 
dissolved in 0.5 ml distilled H2O separately and mixed thoroughly. 
This was reprecipitated with 5 ml of 95% ethanol and recovered by 
centrifugation. The centrifugation was repeated four times until a 
white precipitate was obtained. The final glycogen precipitate was 
dissolved in 2 ml of distilled H2O. 0.5 ml aliquot was taken from the 
unknown glycogen solution obtained from above. Then, 0.5 ml of 
concentrated HCl, followed by 0.5 ml formic acid (88%) and 4 ml of 
anthrone reagent were added in a step wise manner. The anthrone 
reagent was added slowly and mixed thoroughly. 0.5 ml of distilled 
water was treated as above and used as a blank. Several dilutions 
of the glycogen standard (0.2 mg/ml) were prepared. The dilutions 
used were 0.1, 0.2, 0.3, 0.4 ml of standard glycogen solution with 
enough distilled water to make 0.5 ml. These dilutions of glycogen 
standard were then treated as above. A standard curve was 
prepared from this. 
All the tubes containing the solutions were heated in boiling water 
for ten minutes and allowed to cool. A portion of the contents from 
each tube was poured into a cuvette, bubbles were allowed to 
disperse and the absorbance was read. The absorbance was read 
at 630 nm against the blank. Calculation of glycogen was done 


















All values given are mean ±S.E.M of the variables measured. 
Values between two groups were compared using student T-test 
while One-way analysis of variance (ANOVA) was used to compare 
mean values in multiple groups. 
 
 
RESULTS AND DISCUSSION 
 
Effects of 0.7% saline and cortisol on blood glucose 
and glycogen content (liver and muscle) 
 
Infusion of 0.7% amphibian saline had no effect on blood 
glucose level (Figures 1 and 2). The mean fasting 
glucose level in the toad, B. regularis, was 44.4±3.8 
mg/dl. Infusion of cortisol 20 µg/kg caused significant 






Figure 1. Effects of 0.7% amphibian saline cortisol (20 µg/kg) in untreated toads and in prazosin 
treated (0.2 mg/kg), propranolol treated (0.5 mg/kg), and both prazosin (0.2 mg/kg) and propranolol 










Figure 2. Graph of liver and muscle glycogen content (Mg glycogen/100 g fresh liver and muscle 
(mean±S.E.M) in toads infused with 0.7% amphibian saline, cortisol, and pre-treated with 





increase in blood glucose level from a mean basal value 
of 44.4±3.8 mg/dl to maximum value of 71.7±9.7 mg/dl 90 
min post injection and decrease in glycogen content of 
liver and muscle when compared with the control 
(Figures 1 and 2). Cortisol-induced hyperglycaemia was 
delayed and became significant 20 min post-injection 
period (Figure 1) and hyperglycaemia was progressive 
throughout the post- injection period. 
 
 
Effects of pre-treatment with prazosin (0.2 mg/kg) and 
propranolol (0.5 mg/kg) 
 
These are shown in Figure 1. The hyperglycaemic 
response to cortisol infusion was completely abolished by 
propranolol but prazosin did not produce any significant 
effect in cortisol-induced hyperglycaemia when compared 
with the untreated toads (Figure 1). A combination of both 
blockers completely abolished cortisol- induced hypergly-
caemia in B. regularis when compared with the untreated 
toads (Figure 1). Figure 2 shows the effect of adrenergic 
blockers on liver and muscle glycogen. Pre-treatment of 
the toads with prazosin caused significant reduction in 
liver glycogen while pre-treatment with propranolol 
produced no significant reduction in liver and muscle 
glycogen level. The combination of both prazosin and 
propranolol caused non-significant reduction in liver and 
muscle glycogen (Figure 2). 
The rise in blood glucose following cortisol injection in 
this study confirms its hyperglycaemic effect. The results 
agree with findings in frogs (Hanke, 1974, 1978; 
Broughton and DeRoos, 1984; Tavoni et al., 2013) and 
other animal species (Chan and Woo, 1978a; Khani and 
Tayek, 2001). The significantly higher levels of blood 
glucose following cortisol injection in the toad are 
probably due to an enhanced liver gluconeogenesis. 
Cortisol has been reported to exert its hyperglycaemic 
effect through activation of gluconeogenesis (Baxter, 
1979; Renauid and Moon, 1980; Resmini et al., 2009). Al-
Nagdy et al. (1995) reported increased levels of blood 
lactate and pyruvate following cortisone injection.  In the 
present study, the stimulated liver gluconeogenesis may 
account for the decrease in liver and muscle glycogen 
following cortisol injection and compared with the control. 
Therefore, it is not unlikely that both the hepatic and 
muscle glycogen must have contributed some amount of 
glucose under the influence of cortisol. The results of the 
present study in which cortisol caused reduction in liver 
and muscle glycogen agrees with the findings in fishes 
(Foster and Moon, 1986; Vijayan and Leatherland, 1989) 
and in rats (Tavoni et al., 2013). Cortisol, a major 
glucocorticoid exerts its hyperglycaemic effect through 
activation of gluconeogenesis (Baxter, 1979; Renaud and 
Moon, 1980; Khani and Tayek, 2001). Since 0.7% 
amphibian saline injection had no effect on blood 
glucose, the hyperglycaemic effect of cortisol could not 
be ascribed to the stress of the injections. 
In the prazosin  pre-treated animals, the  non-significant  




reduction in cortisol-induced hyperglycaemia seems to 
suggest that the alpha adrenergic receptors may not play 
a significant role in the production of hyperglycaemic 
response to cortisol in the toad. The significant reduction 
of liver glycogen by prazosin also, is an indication of the 
non significant involvement of alpha adrenoceptors in 
cortisol hyperglycaemia. The present findings contrast 
the report in man, that alpha adrenergic blockade by 
phentolamine infusion suppressed plasma adrenocor-
ticotropic hormone (ACTH)  and cortisol level while 
propranolol caused no significant change in plasma 
ACTH and cortisol although it enhanced plasma ACTH 
response to insulin induced hypoglycaemia (Nakai et al; 
1973; Al-Damluji, 1988). Pretreatment with propranolol 
significantly reduced the rise in blood glucose response 
to cortisol injection. Since propranolol is a beta-blocker, it 
seems likely that the ability of cortisol to increase blood 
glucose in toads is mediated through the beta adrenergic 
receptors. Also, the non significant reduction in the liver 
and muscle glycogen in toads by propranolol further 
confirms that the beta adrenergic receptors are involved 
in the cortisol hyperglycaemia. The result is consistent 
with the study in rats in which glucocorticoids enhanced 
β-receptors mediated responses (Davies and Lefkowtig, 
1984; Taylor and Hancox, 2000). Cortisol has been 
reported to exert its effects through the beta adrenergic 
receptors (George et al., 2013).The combination of both 
prazosin and propranolol completely abolished the rise in 
blood glucose following cortisol injection in the toad in the 
present study. Since prazosin alone did not cause a 
significant reduction in cortisol hyperglycaemia, the 
complete abolition of cortisol-induced hyperglycaemia by 
both prazosin and propranolol shows that prazosin 
potentiated the effect of propranolol on cortisol-induced 
hyperglycaemia. In conclusion, the results of the present 
study show that both the alpha and beta adrenergic 
receptors are involved in the cortisol-induced 
hyperglycaemia in the common African toad, B. regularis. 
However, the beta adrenergic receptors played a 
dominant role than the alpha adrenergic receptors in 
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